JosephMThomasMD
Ophthalmology • Beachwood, OHCataract Related, Cornea & External Disease, Refractive Surgery
Thomas Eyecare
Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3619 Park East Dr
Ste 306
Beachwood, OH 44122Phone+1 216-292-9150Fax+1 216-292-9159
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Cataract and Refracrive Surgery, 1996 - 1997- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Ophthalmology, 1993 - 1996
University of HawaiiInternship, Transitional Year, 1992 - 1993
Case Western Reserve University School of MedicineClass of 1992
Certifications & Licensure
OH State Medical License 1996 - 2025- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 63 citationsNovel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse modelsTianxia Li, Dejun Yang, Shijun Zhong, Joseph M. Thomas, Fengtian Xue
Human Molecular Genetics. 2014-12-01 - 80 citationsInterleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-β1 in airway fibroblasts in asthmaRafael Firszt, Dave Francisco, Tony D. Church, Joseph M. Thomas, Jennifer L. Ingram
The European Respiratory Journal. 2014-02-01 - 40 citationsA novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson's disease models.Tianxia Li, Xinhua He, Joseph M. Thomas, Dejun Yang, Shijun Zhong
Plos One. 2015-03-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
